| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Urological Research Laboratory, Departments of Urology [M. J. G. B., F. D., J. A. S.] and Biochemistry [W. J. M. v. d. V.], Radboud University Hospital, P. O. Box 9101, 6500 HB Nijmegen, The Netherlands
One of the major problems in the diagnosis of localized prostatic tumors is to predict the aggressiveness of an individual tumor, which is presumably associated with chance to progression. In an attempt to find molecular markers that are specific for aggressive prostatic cancer cells, we compared steady-state mRNA levels of progressionally related prostatic tumors. The Dunning R-3327-H subline, a relatively benign rat prostatic tumor, was compared to the therefrom derived highly aggressive MatLyLu tumor by differential hybridization analysis. The differential screening revealed 26 complementary DNA clones that detected transcripts overexpressed in MatLyLu. Upon further screening on the entire panel of Dunning R-3327 sublines, it appeared that three clones (pBUS1, pBUS19, and pBUS30), detected transcripts specifically expressed in metastatic rat prostatic tumors. The expression pattern of pBUS19 and pBUS30 suggested a relation between these complementary DNAs. Nucleotide sequence analysis, however, could not yet substantiate this. Computer-assisted comparison of the DNA sequences revealed the presence of rat long terminal repeat-like repetitive elements in pBUS19. The differential expression of repetitive elements in progressionally related tumors is interesting, yet similar findings have not been reported in human malignancies. Nucleotide sequence analysis of pBUS1 indicated that this clone is identical or related to high mobility group protein I(Y), a non-histone nuclear protein. From recent studies it appeared that this protein might be implicated in replication and/or transcription processes and is induced in fast proliferating/undifferentiated cells. The overexpression of high mobility group protein I(Y) correlates rather with metastatic ability than with growth rate; hence it may serve as a valuable marker to identify progressionally advanced prostate cancer cells.
1 These studies were supported by the Dutch Cancer Foundation (NUKC 90-01) and the Royal Dutch Academy of Arts and Sciences.
2 Present address: Center for Human Genetics, University of Leuven, Leuven, Belgium.
3 To whom requests for reprints should be addressed.
Received 8/ 2/90. Accepted 10/26/90.
This article has been cited by other articles:
![]() |
I. Cleynen, C. Huysmans, T. Sasazuki, S. Shirasawa, W. Van de Ven, and K. Peeters Transcriptional Control of the Human High Mobility Group A1 Gene: Basal and Oncogenic Ras-Regulated Expression Cancer Res., May 15, 2007; 67(10): 4620 - 4629. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Edberg, J. N. Adkins, D. L. Springer, and R. Reeves Dynamic and Differential in Vivo Modifications of the Isoform HMGA1a and HMGA1b Chromatin Proteins J. Biol. Chem., March 11, 2005; 280(10): 8961 - 8973. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hommura, M. Katabami, V. D. Leaner, H. Donninger, T. F. Sumter, L. M.S. Resar, and M. J. Birrer HMG-I/Y Is a c-Jun/Activator Protein-1 Target Gene and Is Necessary for c-Jun-Induced Anchorage-Independent Growth in Rat1a Cells Mol. Cancer Res., May 1, 2004; 2(5): 305 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Pierantoni, S. Battista, F. Pentimalli, M. Fedele, R. Visone, A. Federico, M. Santoro, G. Viglietto, and A. Fusco A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas Carcinogenesis, December 1, 2003; 24(12): 1861 - 1869. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Scala, G. Portella, D. Vitagliano, C. Ledent, G. Chiappetta, V. Giancotti, J. Dumont, and A. Fusco HMGI-C gene expression is not required for in vivo thyroid cell transformation Carcinogenesis, February 1, 2001; 22(2): 251 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Reeves, D. D. Edberg, and Y. Li Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells Mol. Cell. Biol., January 15, 2001; 21(2): 575 - 594. [Abstract] [Full Text] |
||||
![]() |
L. J. Wood, M. Mukherjee, C. E. Dolde, Y. Xu, J. F. Maher, T. E. Bunton, J. B. Williams, and L. M. S. Resar HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene Mol. Cell. Biol., August 1, 2000; 20(15): 5490 - 5502. [Abstract] [Full Text] |
||||
![]() |
L. J. Wood, J. F. Maher, T. E. Bunton, and L. M. S. Resar The Oncogenic Properties of the HMG-I Gene Family Cancer Res., August 1, 2000; 60(15): 4256 - 4261. [Abstract] [Full Text] |
||||
![]() |
L. C. FOSTER, P. WIESEL, G. S. HUGGINS, R. PAÑARES, M. T. CHIN, A. PELLACANI, and M. A. PERRELLA Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1{beta} in vascular smooth muscle cells FASEB J, February 1, 2000; 14(2): 368 - 378. [Abstract] [Full Text] |
||||
![]() |
E. van Garderen, H. J. A. van der Poel, J. F. Swennenhuis, E. H. J. Wissink, G. R. Rutteman, E. Hellmén, J. A. Mol, and J. A. Schalken Expression and Molecular Characterization of the Growth Hormone Receptor in Canine Mammary Tissue and Mammary Tumors Endocrinology, December 1, 1999; 140(12): 5907 - 5914. [Abstract] [Full Text] |
||||
![]() |
M. J. G. Bussemakers, A. van Bokhoven, G. W. Verhaegh, F. P. Smit, H. F. M. Karthaus, J. A. Schalken, F. M. J. Debruyne, N. Ru, and W. B. Isaacs DD3::A New Prostate-specific Gene, Highly Overexpressed in Prostate Cancer Cancer Res., December 1, 1999; 59(23): 5975 - 5979. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nacht, A. T. Ferguson, W. Zhang, J. M. Petroziello, B. P. Cook, Y. H. Gao, S. Maguire, D. Riley, G. Coppola, G. M. Landes, et al. Combining Serial Analysis of Gene Expression and Array Technologies to Identify Genes Differentially Expressed in Breast Cancer Cancer Res., November 1, 1999; 59(21): 5464 - 5470. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Liu, F. K. Guerra-Vladusic, S. Kurakata, R. Lupu, and T. Kohwi-Shigematsu HMG-I(Y) Recognizes Base-unpairing Regions of Matrix Attachment Sequences and Its Increased Expression Is Directly Linked to Metastatic Breast Cancer Phenotype Cancer Res., November 1, 1999; 59(22): 5695 - 5703. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Rondinelli and J. V. Tricoli CLAR1, a Novel Gene That Exhibits Enhanced Expression in Advanced Human Prostate Cancer Clin. Cancer Res., June 1, 1999; 5(6): 1595 - 1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Giannini, L. Di Marcotullio, E. Ristori, M. Zani, M. Crescenzi, S. Scarpa, G. Piaggio, A. Vacca, F. A. Peverali, F. Diana, et al. HMGI(Y) and HMGI-C Genes Are Expressed in Neuroblastoma Cell Lines and Tumors and Affect Retinoic Acid Responsiveness Cancer Res., May 1, 1999; 59(10): 2484 - 2492. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Abe, T. Watanabe, M. Sugiyama, H. Uchimura, G. Chiappetta, A. Fusco, and Y. Atomi Determination of High Mobility Group I(Y) Expression Level in Colorectal Neoplasias: A Potential Diagnostic Marker Cancer Res., March 1, 1999; 59(6): 1169 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pellacani, M. T. Chin, P. Wiesel, M. Ibanez, A. Patel, S.-F. Yet, C.-M. Hsieh, J. D. Paulauskis, R. Reeves, M.-E. Lee, et al. Induction of High Mobility Group-I(Y) Protein by Endotoxin and Interleukin-1beta in Vascular Smooth Muscle Cells. ROLE IN ACTIVATION OF INDUCIBLE NITRIC OXIDE SYNTHASE J. Biol. Chem., January 15, 1999; 274(3): 1525 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Bonne, J van Hengel, F Nollet, P Kools, and F van Roy Plakophilin-3, a novel armadillo-like protein present in nuclei and desmosomes of epithelial cells J. Cell Sci., January 7, 1999; 112(14): 2265 - 2276. [Abstract] [PDF] |
||||
![]() |
S. A. Ogram and R. Reeves Differential Regulation of a Multipromoter Gene J. Biol. Chem., June 9, 1995; 270(23): 14235 - 14242. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Nissen and R. Reeves Changes in Superhelicity Are Introduced into Closed Circular DNA by Binding of High Mobility Group Protein I/Y J. Biol. Chem., March 3, 1995; 270(9): 4355 - 4360. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |